Increased serum pancreatic enzymes in uremia: Relation with treatment modality and pancreatic involvement

Pancreas

Volumn 13, Issue 4, 1996, Pages 350-355

  Masoero, G ^a   Bruno, M ^a   Gallo, L ^a   Colaferro, S ^a   Cosseddu, D ^a   Vacha, G M ^a  

^a MAURIZIANO HOSPITAL   (Italy)

Author keywords

Amylase; Dialysis; Lipase; Parathyroid hormone; Renal failure; Renal transplantation

Indexed keywords

CREATININE; PANCREAS ENZYME; PARATHYROID HORMONE; TRIACYLGLYCEROL;

ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENZYME BLOOD LEVEL; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METABOLIC BALANCE; PANCREAS DISEASE; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; UREMIA; URINARY EXCRETION;

EID: 0029859382     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199611000-00004     Document Type: Article

References (18)

1. Montalto G, Carroccio A, Sparacino V, et al. Pancreatic enzymes in chronic renal failure and transplant patients. Int J Pancreatol 1992;3:211-7.
2. Vaziri ND, Chang D, Malekpour A, Radaht S. Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis. Am J Gastroenterol 1987;4:410-2.
3. Royse VL, Jensen DM, Corwin HL. Pancreatic enzymes in chronic renal failure. Arch Intern Med 1987;147:537-9.
4. Collen MJ, Ansher AF, Chapmen AB, Mackow RC, Lewis JH. Serum amylase in patients with renal insufficiency and renal failure. Am J Gastroenterol 1990;10:1377-80.
5. Berk JE, Fridhandler L, Ness RL. Amylase and isoamylase activities in renal insufficiency. Ann Intern Med 1979;90: 351-3.
6. Lin XZ, Chen TW, Wang SS, et al. Pancreatic enzymes in uremic patients with or without dialysis. Clin Biochem 1988; 21:189-92.
7. Avram MM. High prevalence of pancreatic disease in chronic renal failure. Nephron 1977;18:68-71.
8. Vaziri ND, Dure-Smith B, Miller R, Mirahmadi M. Pancreatic pathology in chronic dialysis patients. An autopsy study in 78 cases. Nephron 1987;46:347-9.
9. Sombolos K, McNamee P, Mitwali A, Rabinovich S, Oreopoulos DG. Autopsy findings in patients treated by continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1986;6:130-5.
10. Araki T, Ueda M, Ogawa K, Tsuji T. Histological pancreatitis in end-stage renal disease. Int J Pancreatol 1992;3: 263-9.
11. Tsianos EV, Dardamanis MA, Elisaf F, Vasakos S, Siamopoulos KC. The value of α-amylase and isoamylase determination in chronic renal failure patients. Int J Pancreatol 1994;2:105-11.
12. Caruana RJ, Burkart J, Segraves D, Smallwood S, Haymore J, Disher B. Serum and peritoneal fluid amylase levels in CAPD. Normal values and clinical usefulness. Am J Nephrol 1987;7:169-72.
13. Bastani B, Mifflin TE, Lovell MA, Westervelt FB, Bruns DE. Serum amylase in chronic and end-stage renal failure: effects of mode of therapy, race, diabetes and peritonitis. Am J Nephrol 1987;7:292-9.
14. Avram RM, Iancu M. Pancreatic disease in uremia and parathyroid hormone excess. Nephron 1982;32:60-2.
15. Magnusson M, Magnusson K-E, Sundqvist T, Denneberg T. Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: effects of low- and high-protein diets. Nephron 1990;56:306-11.
16. Magnusson M, Magnusson K-E, Sundqvist T, Denneberg T. Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. Gut 1991;32:754-9.
17. Gnadinger MP, Eigenmann F, Bekier A, Galeazzi RL. Pseudopancreatitis in enteroinvasive Salmonella enteritidis infection. Schweiz Med Wochenschr 1993;30:1482-6.
18. Zuckerman MJ, Watts MT, Bhatt BD, Ho H. Intestinal permeability to [(51) Cr] EDTA in infectious diarrhea. Dig Dis Sci 1993;9:1651-7.